Found: 83
Select item for more details and to access through your institution.
Value of autotaxin for hepatocellular carcinoma risk assessment in chronic hepatitis B patients treated with nucleos(t)ide analogs.
- Published in:
- Hepatology Research, 2024, v. 54, n. 11, p. 981, doi. 10.1111/hepr.14042
- By:
- Publication type:
- Article
Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients.
- Published in:
- Journal of Gastroenterology, 2013, v. 48, n. 10, p. 1188, doi. 10.1007/s00535-012-0737-2
- By:
- Publication type:
- Article
IL28B polymorphism is associated with fatty change in the liver of chronic hepatitis C patients.
- Published in:
- Journal of Gastroenterology, 2012, v. 47, n. 7, p. 834, doi. 10.1007/s00535-012-0550-y
- By:
- Publication type:
- Article
Clinicopathological features of elderly patients with hepatitis C virus-related hepatocellular carcinoma.
- Published in:
- Journal of Gastroenterology, 2008, v. 43, n. 7, p. 550, doi. 10.1007/s00535-008-2194-5
- By:
- Publication type:
- Article
Pretreatment predictor of response, time to progression, and survival to intraarterial 5-fluorouracil/interferon combination therapy in patients with advanced hepatocellular carcinoma.
- Published in:
- Journal of Gastroenterology, 2007, v. 42, n. 10, p. 845, doi. 10.1007/s00535-007-2099-8
- By:
- Publication type:
- Article
Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02016-3
- By:
- Publication type:
- Article
Increasing incidence of non-HBV- and non-HCV-related hepatocellular carcinoma: single-institution 20-year study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Similar effects of recombinant interferon-α-2b and natural interferon-α when combined with intra-arterial 5-fluorouracil for the treatment of advanced hepatocellular carcinoma.
- Published in:
- Liver International, 2007, v. 27, n. 9, p. 1209, doi. 10.1111/j.1478-3231.2007.01554.x
- By:
- Publication type:
- Article
Ribavirin induces hepatitis C virus genome mutations in chronic hepatitis patients who failed to respond to prior daclatasvir plus asunaprevir therapy.
- Published in:
- Journal of Medical Virology, 2020, v. 92, n. 2, p. 210, doi. 10.1002/jmv.25602
- By:
- Publication type:
- Article
The impact of interferon‐free direct‐acting antivirals on clinical outcome after curative treatment for hepatitis C virus–associated hepatocellular carcinoma: Comparison with interferon‐based therapy.
- Published in:
- Journal of Medical Virology, 2019, v. 91, n. 4, p. 650, doi. 10.1002/jmv.25352
- By:
- Publication type:
- Article
Advanced liver fibrosis effects on the response to sofosbuvir‐based antiviral therapies for chronic hepatitis C.
- Published in:
- Journal of Medical Virology, 2018, v. 90, n. 12, p. 1834, doi. 10.1002/jmv.25267
- By:
- Publication type:
- Article
Emergence of drug resistance-associated variants and changes in serum lipid profiles in sofosbuvir plus ledipasvir-treated chronic hepatitis C patients.
- Published in:
- Journal of Medical Virology, 2017, v. 89, n. 11, p. 1963, doi. 10.1002/jmv.24885
- By:
- Publication type:
- Article
Efficacy and safety of daclatasvir plus asunaprevir therapy for chronic hepatitis C patients with renal dysfunction.
- Published in:
- Journal of Medical Virology, 2017, v. 89, n. 4, p. 665, doi. 10.1002/jmv.24679
- By:
- Publication type:
- Article
Circulating microRNA-22 correlates with microRNA-122 and represents viral replication and liver injury in patients with chronic hepatitis B.
- Published in:
- Journal of Medical Virology, 2013, v. 85, n. 5, p. 789, doi. 10.1002/jmv.23540
- By:
- Publication type:
- Article
Inverse association of IL28B genotype and liver mRNA expression of genes promoting or suppressing antiviral state.
- Published in:
- Journal of Medical Virology, 2011, v. 83, n. 9, p. 1597, doi. 10.1002/jmv.22158
- By:
- Publication type:
- Article
Common genetic polymorphism of ITPA gene affects ribavirin-induced anemia and effect of peg-interferon plus ribavirin therapy.
- Published in:
- Journal of Medical Virology, 2011, v. 83, n. 6, p. 1048, doi. 10.1002/jmv.22069
- By:
- Publication type:
- Article
Clinical Outcomes of Switching from Zoledronic Acid to Denosumab for the Management of Severe Bone Metastasis from Hepatocellular Carcinoma: A Single-Center, Open-Label, Prospective Intervention Trial.
- Published in:
- Yonago Acta Medica, 2023, v. 66, n. 4, p. 422, doi. 10.33160/yam.2023.11.007
- By:
- Publication type:
- Article
Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers.
- Published in:
- Nature Genetics, 2011, v. 43, n. 8, p. 797, doi. 10.1038/ng.876
- By:
- Publication type:
- Article
Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations.
- Published in:
- Nature Genetics, 2010, v. 42, n. 10, p. 893, doi. 10.1038/ng.667
- By:
- Publication type:
- Article
Hepatic venous pressure gradient after balloon-occluded retrograde transvenous obliteration and liver stiffness measurement predict the prognosis of patients with gastric varices.
- Published in:
- BMC Gastroenterology, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12876-022-02616-z
- By:
- Publication type:
- Article
Real‐world efficacy of sofosbuvir plus velpatasvir therapy for patients with hepatitis C virus‐related decompensated cirrhosis.
- Published in:
- Hepatology Research, 2020, v. 50, n. 11, p. 1234, doi. 10.1111/hepr.13555
- By:
- Publication type:
- Article
Impact of viral eradication by direct‐acting antivirals on the risk of hepatocellular carcinoma development, prognosis, and portal hypertension in hepatitis C virus‐related compensated cirrhosis patients.
- Published in:
- Hepatology Research, 2020, v. 50, n. 11, p. 1222, doi. 10.1111/hepr.13554
- By:
- Publication type:
- Article
Risk factors for exacerbation of gastroesophageal varices and portosystemic encephalopathy during treatment with nucleos(t)ide analogs for hepatitis B virus‐related cirrhosis.
- Published in:
- Hepatology Research, 2018, v. 48, n. 4, p. 264, doi. 10.1111/hepr.12996
- By:
- Publication type:
- Article
IFNL4 polymorphism effects on outcome of simeprevir, peginterferon, and ribavirin therapy for older patients with genotype 1 chronic hepatitis C.
- Published in:
- Hepatology Research, 2017, v. 47, n. 3, p. E5, doi. 10.1111/hepr.12715
- By:
- Publication type:
- Article
Improvement of renal dysfunction in a patient with hepatitis C virus-related liver cirrhosis by daclatasvir and asunaprevir combination therapy: A case report.
- Published in:
- Hepatology Research, 2016, v. 46, n. 9, p. 944, doi. 10.1111/hepr.12629
- By:
- Publication type:
- Article
Two patients treated with pegylated interferon/ribavirin/telaprevir triple therapy for recurrent hepatitis C after living donor liver transplantation.
- Published in:
- Hepatology Research, 2014, v. 44, n. 12, p. 1259, doi. 10.1111/hepr.12296
- By:
- Publication type:
- Article
Eradication of hepatitis C virus genotype 1 after liver transplantation by interferon therapy before surgery: Report of three patients with analysis of interleukin-28 polymorphism, hepatitis C virus core region and interferon-sensitivity determining region
- Published in:
- Hepatology Research, 2011, v. 41, n. 11, p. 1126, doi. 10.1111/j.1872-034X.2011.00853.x
- By:
- Publication type:
- Article
Effects of structural variations of APOBEC3A and APOBEC3B genes in chronic hepatitis B virus infection.
- Published in:
- Hepatology Research, 2009, v. 39, n. 12, p. 1159, doi. 10.1111/j.1872-034X.2009.00566.x
- By:
- Publication type:
- Article
Circulating cytokines and angiogenic factors based signature associated with the relative dose intensity during treatment in patients with advanced hepatocellular carcinoma receiving lenvatinib.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920922051
- By:
- Publication type:
- Article
Rapid, Sensitive, and Accurate Evaluation of Drug Resistant Mutant (NS5A-Y93H) Strain Frequency in Genotype 1b HCV by Invader Assay.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0130022
- By:
- Publication type:
- Article
HLA-DQB1*03 Confers Susceptibility to Chronic Hepatitis C in Japanese: A Genome-Wide Association Study.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0084226
- By:
- Publication type:
- Article
Genetic Analyses Reveal a Role for Vitamin D Insufficiency in HCV-Associated Hepatocellular Carcinoma Development
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0064053
- By:
- Publication type:
- Article
Identification of a Functional Variant in the <i>MICA</i> Promoter Which Regulates <i>MICA</i> Expression and Increases HCV-Related Hepatocellular Carcinoma Risk.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0061279
- By:
- Publication type:
- Article
Hepatitis B Virus-Specific miRNAs and Argonaute2 Play a Role in the Viral Life Cycle.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0047490
- By:
- Publication type:
- Article
Hepatitis C Virus Infection Suppresses the Interferon Response in the Liver of the Human Hepatocyte Chimeric Mouse.
- Published in:
- PLoS ONE, 2011, v. 6, n. 8, p. 1, doi. 10.1371/journal.pone.0023856
- By:
- Publication type:
- Article
IL28B But Not ITPA Polymorphism Is Predictive of Response to Pegylated Interferon, Ribavirin, and Telaprevir Triple Therapy in Patients With Genotype 1 Hepatitis C.
- Published in:
- Journal of Infectious Diseases, 2011, v. 204, n. 1, p. 84, doi. 10.1093/infdis/jir210
- By:
- Publication type:
- Article
G-to-A Hypermutation in Hepatitis B Virus (HBV) and Clinical Course of Patients with Chronic HBV Infection.
- Published in:
- Journal of Infectious Diseases, 2009, v. 199, n. 11, p. 1599, doi. 10.1086/598951
- By:
- Publication type:
- Article
Peripheral T Cell Subpopulations as a Potential Surrogate Biomarker during Atezolizumab plus Bevacizumab Treatment for Hepatocellular Carcinoma.
- Published in:
- Cancers, 2024, v. 16, n. 7, p. 1328, doi. 10.3390/cancers16071328
- By:
- Publication type:
- Article
Therapeutic Efficacy and Safety of Lenvatinib after Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 22, p. 5406, doi. 10.3390/cancers15225406
- By:
- Publication type:
- Article
Association of Hepatobiliary Phase of Gadoxetic-Acid-Enhanced MRI Imaging with Immune Microenvironment and Response to Atezolizumab Plus Bevacizumab Treatment.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4234, doi. 10.3390/cancers15174234
- By:
- Publication type:
- Article
Evaluation of Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma Using the Combination of Response Evaluation Criteria in Solid Tumors and Alpha-Fetoprotein.
- Published in:
- Cancers, 2023, v. 15, n. 8, p. 2304, doi. 10.3390/cancers15082304
- By:
- Publication type:
- Article
Efficacy and safety of atezolizumab plus bevacizumab in patients with portal hypertension for unresectable hepatocellular carcinoma.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 5, p. 1, doi. 10.1002/cam4.7025
- By:
- Publication type:
- Article
Correlation between serum pro‐inflammatory cytokine levels and the prognosis of the patients with acute liver failure.
- Published in:
- Journal of Gastroenterology & Hepatology, 2023, v. 38, n. 9, p. 1637, doi. 10.1111/jgh.16300
- By:
- Publication type:
- Article
Extracellular water to total body water ratio obtained by bioelectrical impedance analysis determines the dose intensity of lenvatinib for the treatment of patients with advanced hepatocellular carcinoma.
- Published in:
- Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 6, p. 1685, doi. 10.1111/jgh.15377
- By:
- Publication type:
- Article
The presence of vessels encapsulating tumor clusters is associated with an immunosuppressive tumor microenvironment in hepatocellular carcinoma.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 12, p. 2278, doi. 10.1002/ijc.34247
- By:
- Publication type:
- Article
In vitro analysis of hepatic stellate cell activation influenced by transmembrane 6 superfamily 2 polymorphism.
- Published in:
- Molecular Medicine Reports, 2021, v. 23, n. 1, p. N.PAG
- By:
- Publication type:
- Article
Comparative study on the replication of HCV1b genome between wild‐type and cell culture‐adaptive mutant in regard to sensitivities against anti‐HCV drugs.
- Published in:
- Microbiology & Immunology, 2020, v. 64, n. 4, p. 296, doi. 10.1111/1348-0421.12768
- By:
- Publication type:
- Article
Clinical Usefulness of Serum Autotaxin for Early Prediction of Relapse in Male Patients with Type 1 Autoimmune Pancreatitis.
- Published in:
- Digestive Diseases & Sciences, 2021, v. 66, n. 4, p. 1268, doi. 10.1007/s10620-020-06338-8
- By:
- Publication type:
- Article
Pruritus in patients with chronic liver disease and serum autotaxin levels in patients with primary biliary cholangitis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Low-Dose Alcohol-Induced Inhibition of Mouse Orthotopically Transplanted Tumors Is Associated with T-Cell Response.
- Published in:
- Pathobiology, 2023, v. 90, n. 1, p. 22, doi. 10.1159/000524478
- By:
- Publication type:
- Article